Biophytis S.A. (NASDAQ:BPTS – Get Rating) was the recipient of a significant increase in short interest in July. As of July 15th, there was short interest totalling 27,700 shares, an increase of 91.0% from the June 30th total of 14,500 shares. Based on an average daily volume of 4,400 shares, the short-interest ratio is presently 6.3 days.
Biophytis Price Performance
NASDAQ BPTS opened at $0.87 on Monday. Biophytis has a twelve month low of $0.81 and a twelve month high of $9.98. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.10. The firm’s 50 day moving average price is $1.07 and its two-hundred day moving average price is $2.28.
Wall Street Analysts Forecast Growth
Separately, HC Wainwright reissued a “buy” rating and set a $15.00 target price on shares of Biophytis in a report on Tuesday, July 5th.
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases.
- Get a free copy of the StockNews.com research report on Biophytis (BPTS)
- Use These To Find Your Stock’s Support and Resistance Levels
- Is Boeing Stock is Ready for Lift-Off ?
- Elon Musk is Out, But Should You Be In Twitter Stock?
- 3 Earnings Announcements That Could Surprise
- Twitter’s Up For Third Week In A Row: What’s Next For The Stock?
Receive News & Ratings for Biophytis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biophytis and related companies with MarketBeat.com's FREE daily email newsletter.